Glaukos Change in Assets/Liabilities 2014-2025 | GKOS

Glaukos change in assets/liabilities for the twelve months ending June 30, 2025 was $0.010B, a 2673.14% increase year-over-year.

  • Glaukos annual change in assets/liabilities for 2024 was $0.006B, a 2176.41% increase from 2023.
  • Glaukos annual change in assets/liabilities for 2023 was $0B, a 122.49% decline from 2022.
  • Glaukos annual change in assets/liabilities for 2022 was $-0.001B, a 213.4% increase from 2021.

Glaukos Change in Assets/Liabilities 2014-2025 | GKOS

  • Glaukos annual change in assets/liabilities for 2024 was $0.006B, a 2176.41% increase from 2023.
  • Glaukos annual change in assets/liabilities for 2023 was $0B, a 122.49% decline from 2022.
  • Glaukos annual change in assets/liabilities for 2022 was $-0.001B, a 213.4% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$184.7B
Intuitive Surgical (ISRG)$172.2B
IDEXX Laboratories (IDXX)$52.1B
Edwards Lifesciences (EW)$45.9B
Alcon (ALC)$43.3B
IQVIA Holdings (IQV)$32.5B
DexCom (DXCM)$31.7B
Mettler-Toledo (MTD)$27B
STERIS (STE)$24.2B
Waters (WAT)$17.4B
SONOVA HOLDING (SONVY)$16.7B
Hologic (HOLX)$15.1B
Penumbra (PEN)$9.9B
Sysmex ADR (SSMXY)$8.5B
Masimo (MASI)$8.4B
Globus Medical (GMED)$8.2B
Teleflex (TFX)$5.3B
TransMedics (TMDX)$4.3B
Integer Holdings (ITGR)$3.7B
LivaNova (LIVN)$2.9B
Veracyte (VCYT)$2.4B
Alphatec Holdings (ATEC)$2.3B
PROCEPT BioRobotics (PRCT)$2.3B
Artivion (AORT)$2B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.9B
Integra LifeSciences Holdings (IART)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1.1B